Evaluation of Samjunghwan, a traditional medicine, for neuroprotection against damage by amyloid-beta in rat cortical neurons

Journal of Ethnopharmacology

Volumn 130, Issue 3, 2010, Pages 625-630

  Kim, Hyo Geun ^a   Ju, Mi Sun ^a   Park, Hanbyeol ^a   Seo, Yongtaek ^a   Jang, Young Pyo ^a   Hong, Jongki ^a   Oh, Myung Sook ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Alzheimer's disease; Amyloid beta; Neuroprotective; Samjunghwan

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; CASPASE 3; CYTOCHROME C; HERBACEOUS AGENT; NEUROPROTECTIVE AGENT; PROTEIN BAX; PROTEIN BCL 2; SAMJUNGHWAN EXTRACT; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (25-35); PEPTIDE FRAGMENT; PLANT EXTRACT;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL; CELL MEMBRANE DEPOLARIZATION; DRUG MECHANISM; ENZYME ACTIVATION; HERBAL MEDICINE; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; RAT; SAMJUNGHWAN; ANIMAL; ATRACTYLODES; BRAIN CORTEX; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; ISOLATION AND PURIFICATION; KOREAN MEDICINE; LYCIUM; METABOLISM; MITOCHONDRION; MORUS; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; TOXICITY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; ATRACTYLODES; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; LYCIUM; MEDICINE, KOREAN TRADITIONAL; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MORUS; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; AMYLOID BETA-PEPTIDES;

RATTUS;

EID: 77954951291     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.05.040     Document Type: Article

References (21)

1. Bamberger M.E., Landreth G.E. Inflammation, apoptosis, and Alzheimer's disease. The Neuroscientist 2002, 8:276-283.
2. Bottiglieri T., Hyland K., Reynolds E.H. The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders. Drugs 1994, 48:137-152.
3. Eckert A., Marques C.A., Keil U., Schussel K., Muller W.E. Increased apoptotic cell death in sporadic and genetic Alzheimer's disease. Annals of the New York Academy of Sciences 2003, 1010:604-609.
4. Forman M.S., Trojanowski J.Q., Lee V.M.Y. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nature Medicine 2004, 10:1055-1063.
5. Hartmann A., Hunot S., Michel P.P., Muriel M.P., Vyas S., Faucheux B.A., Mouatt-Prigent A., Turmel H., Srinivasan A., Ruberg M. Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:2875-2880.
6. Heo J. Dongeuibogam 1999, Bupin Publishes Co., Korea, translated edition by a committee for translation, pp. 131-132.
7. Kang T.H., Hur J.Y., Kim H.B., Ryu J.H., Kim S.Y. Neuroprotective effects of the cyanidin-3-O-β-d-glucopyranoside isolated from mulberry fruit against cerebral ischemia. Neuroscience letters 2006, 391:122-126.
8. Kim H.J., Jang Y.P. Direct analysis of curcumin in turmeric by DART-MS. Phytochemical Anaysis 2009, 20:372-377.
9. Kim J., Kim G., Koo B. Effects of Samjung-hwan (Sānjīngwán) on obesity and lipid metabolism in rats with high fat diet. Journal of Oriental Neuropsychiatry 2009, 20:47-60.
10. Kim S., Jeong J. Effects of Samjunghwan on the IL-1β gene expression in the macrophage. Journal of Korean Oriental Internal Medicine 2006, 27:228-236.
11. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997, 275:1132-1136.
12. Lee D., Jeong J. Peroxinitrite scavenging activity of Samjunghwan. Journal of Korean Oriental Internal Medicine 2006, 27:178-187.
13. Lee S., Kim G., Koo B. Experimental study on the antidepressant effect of Sam-Jeong-Hwan. Journal of Oriental Neuropsychiatry 2008, 19:101-115.
14. Paradis E., Douillard H., Koutroumanis M., Goodyer C., LeBlanc A. Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons. Journal of Neuroscience 1996, 16:7533-7539.
15. Slee E.A., Harte M.T., Kluck R.M., Wolf B.B., Casiano C.A., Newmeyer D.D., Wang H.G., Reed J.C., Nicholson D.W., Alnemri E.S. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2,-3,-6,-7,-8, and-10 in a caspase-9-dependent manner. Journal of Cell Biology 1999, 144:281-292.
16. Su J.H., Zhao M., Anderson A.J., Srinivasan A., Cotman C.W. Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. Brain research 2001, 898:350-357.
17. Tohda C., Matsumoto N., Zou K., Meselhy M.R., Komatsu K. Aβ (25-35)-induced memory impairment, axonal atrophy and synaptic loss are ameliorated by M1, a metabolite of protopanaxadiol-type saponins. Neuropsycopharmacology 2004, 29:860-868.
18. Tohda C., Tamura T., Matsuyama S., Komatsu K. Promotion of axonal maturation and prevention of memory loss in mice by extracts of Astragalus mongholicus. British Journal of Pharmacology 2006, 149:532-541.
19. Toyoda-One Y., Maeda M., Nakao M., Yoshimura M., Sugiura-Tomimori N., Fukami H. 2-O-(beta-d-Glucopyranosyl)ascorbic acid, a novel ascorbic acid analogue isolated from Lycium Fruit. Journal of Agricultural Food Chemistry 2004, 52:2092-2096.
20. Wei Z., Mousseau D.D., Richardson J.S., Dyck L.E., Li X.M. Atypical antipsychotics attenuate neurotoxicity of β-amyloid (25-35) by modulating Bax and Bcl-Xl/s expression and localization. Journal of Neuroscience Research 2003, 74:942-947.
21. Wolter K.G., Hsu Y.T., Smith C.L., Nechushtan A., Xi X.G., Youle R.J. Movement of Bax from the cytosol to mitochondria during apoptosis. Journal of Cell Biology 1997, 139:1281-1292.